dexmedetomidine has been researched along with threonine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
| Chang, RC; Ho, YS; Huang, C; Irwin, MG; Ng, OT; Wong, GT | 1 |
2 other study(ies) available for dexmedetomidine and threonine
| Article | Year |
|---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
Dexmedetomidine directly increases tau phosphorylation.
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Brain; Cells, Cultured; Cerebral Cortex; Dexmedetomidine; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Male; Neurons; Okadaic Acid; Phosphorylation; Rats; Rats, Sprague-Dawley; Serine; tau Proteins; Threonine; Time Factors | 2015 |